-
Moderna's COVID-19 vaccine is stable in refrigerators for 30 days, easing concerns around large-scale rolloutA week after Pfizer posted impressive early coronavirus vaccine efficacy numbers, Moderna took the spotlight early Monday withimpressive findings of its own. But separatefrom itsbigannouncement, the2020/11/2
-
Pharmaceutical Excipient Market Research Report by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19- The Global Pharmaceutical Excipient Market is expected to grow from USD 6,775.32 Million in 2019 to USD 9,453.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.70%.- On the2020/10/26
-
CDC's distribution road map, safety monitoring plans plus other takeaways from FDA's big COVID-19 vaccine meetingIn less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic. Concerns remain, though, and, amid that backdrop, top gov2020/10/23
-
HHS Secretary Azar discussed firing FDA chief Hahn after showdown over COVID-19 vaccine guidance: PoliticoPresident Donald Trump touted a COVID-19 vaccine ready for Election Day, and behind the scenes, his officials tried to make it happen. But despite intense pressure, the FDA publicly rolled out strict2020/10/22
-
Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine trial participantsModerna is one step closer to a COVID-19 vaccine. Racing ahead with its candidate, mRNA-1273, the biotech has nowfinishedenrolling the 30,000 participants needed for its late-stage trial. Testing the2020/10/22
-
Lonza plots $93M expansion to capsule manufacturing, adding billions of doses per yearWhen CDMO Lonza shelled out $5.5 billion for capsule maker Capsugel in 2017, it made a big bet the booming capsule market would drive revenue. Now, with demand continuing to grow, Lonza is putting an2020/10/21
-
California CDMO plots ambitious expansion in Geneva in biologics manufacturing playBiologics have blossomed in recent years as a lucrative market for contract manufacturers, with drugmakers dropping big bucks in the field. A California CDMO is hoping to splash into the frayin a big2020/10/21
-
Does Roche's Actemra work in COVID-19? New studies once again paint mixed pictureRoche’s arthritis drug Actemra was one of the earliest-identified COVID-19 treatment prospects. But the latest clinical studies have yielded mixed data—and seemingly contradictory results. A large ob2020/10/20
-
Purdue reaches $8B settlement on federal opioid charges—but will it ever pay that amount?After years in court over its role in the nation's opioid crisis, Purdue Pharma has signed a massive settlement to walk away from federal civil and criminal charges. But as the company wades throught2020/10/20
-
GlaxoSmithKline offloads Polish plant with 700 workers to French CDMO DelpharmWith plans to take its consumer healthcare joint venture with Pfizer public in the next few years, GlaxoSmithKline has been in Marie Kondomode for some of its expansive global assets. After cutting a2020/10/19